Literature DB >> 23959368

Reproductive endocrinology: maternal cholestasis and offspring metabolic abnormalities.

Mina Desai1, Michael G Ross.   

Abstract

Papacleovoulou and colleagues demonstrate that maternal cholestasis during pregnancy is associated with offspring adiposity and metabolic abnormalities, both in humans and in mice. This study reinforces the overwhelming evidence of the critical role of the in utero environment as a major determinant of adult health and disease.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23959368      PMCID： PMC4012608          DOI： 10.1038/nrendo.2013.165

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


  9 in total

Review 1.  Cholestasis of pregnancy.

Authors:  Bhuvan Pathak; Lili Sheibani; Richard H Lee
Journal:  Obstet Gynecol Clin North Am       Date:  2010-06       Impact factor: 2.844

Review 2.  The thrifty phenotype hypothesis.

Authors:  C N Hales; D J Barker
Journal:  Br Med Bull       Date:  2001       Impact factor: 4.291

Review 3.  The role of maternal-fetal cholesterol transport in early fetal life: current insights.

Authors:  Maria E Baardman; Wilhelmina S Kerstjens-Frederikse; Rolf M F Berger; Marian K Bakker; Robert M W Hofstra; Torsten Plösch
Journal:  Biol Reprod       Date:  2013-01-31       Impact factor: 4.285

4.  Effect of maternal cholestasis on biliary lipid and bile acid secretion in the infant rat.

Authors:  M Y El-Mir; M J Monte; A I Morales; M Arevalo; M A Serrano; J J Marin
Journal:  Hepatology       Date:  1997-09       Impact factor: 17.425

Review 5.  The pharmacological management of intrahepatic cholestasis of pregnancy.

Authors:  Francesco Azzaroli; Laura Turco; Andrea Lisotti; Claudio Calvanese; Giuseppe Mazzella
Journal:  Curr Clin Pharmacol       Date:  2011-02

Review 6.  Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta-analysis.

Authors:  Yannick Bacq; Loïc Sentilhes; Humberto B Reyes; Anna Glantz; Jurate Kondrackiene; Tomas Binder; Pier Luigi Nicastri; Anna Locatelli; Annarosa Floreani; Ismael Hernandez; Vincent Di Martino
Journal:  Gastroenterology       Date:  2012-08-11       Impact factor: 22.682

7.  Reference standard for serum bile acids in pregnancy.

Authors:  N Egan; A Bartels; A S Khashan; D I Broadhurst; C Joyce; J O'Mullane; K O'Donoghue
Journal:  BJOG       Date:  2012-01-18       Impact factor: 6.531

8.  Elevated levels of bile acids in colostrum of patients with cholestasis of pregnancy are decreased following ursodeoxycholic acid therapy [see comemnts].

Authors:  D Brites; C M Rodrigues
Journal:  J Hepatol       Date:  1998-11       Impact factor: 25.083

9.  Maternal cholestasis during pregnancy programs metabolic disease in offspring.

Authors:  Georgia Papacleovoulou; Shadi Abu-Hayyeh; Evanthia Nikolopoulou; Oscar Briz; Bryn M Owen; Vanya Nikolova; Caroline Ovadia; Xiao Huang; Marja Vaarasmaki; Marc Baumann; Eugene Jansen; Christiane Albrecht; Marjo-Riitta Jarvelin; Jose J G Marin; A S Knisely; Catherine Williamson
Journal:  J Clin Invest       Date:  2013-06-24       Impact factor: 14.808
  9 in total
  3 in total

1.  Elevated serum squalene and cholesterol synthesis markers in pregnant obese women with gestational diabetes mellitus.

Authors:  Helena E Miettinen; Kristiina Rönö; Saila Koivusalo; Beata Stach-Lempinen; Maritta Pöyhönen-Alho; Johan G Eriksson; Timo P Hiltunen; Helena Gylling
Journal:  J Lipid Res       Date:  2014-10-09       Impact factor: 5.922

2.  Total serum bile acids or serum bile acid profile, or both, for the diagnosis of intrahepatic cholestasis of pregnancy.

Authors:  Cristina Manzotti; Giovanni Casazza; Tea Stimac; Dimitrinka Nikolova; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2019-07-05

3.  Continuous association of total bile acid levels with the risk of small for gestational age infants.

Authors:  Li Li; Wei Chen; Li Ma; Zhi Bing Liu; Xue Lu; Xing Xing Gao; Yan Liu; Hua Wang; Mei Zhao; Xiao Lan Li; Lin Cong; De Xiang Xu; Yuan Hua Chen
Journal:  Sci Rep       Date:  2020-06-09       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.